...
首页> 外文期刊>Clinical & developmental immunology. >Vaccines for TB: Lessons from the Past Translating into Future Potentials
【24h】

Vaccines for TB: Lessons from the Past Translating into Future Potentials

机译:结核病疫苗:过去的经验教训转化为未来的潜力

获取原文
获取原文并翻译 | 示例

摘要

Development of vaccines for infectious diseases has come a long way with recent advancements in adjuvant developments and discovery of new antigens that are capable of eliciting strong immunological responses for sterile eradication of disease. Tuberculosis (TB) that kills nearly 2 million of the population every year is also one of the highlights of the recent developments. The availability or not of diagnostic methods for infection has implications for the control of the disease by the health systems but is not related to the immune surveillance, a phenomenon derived from the interaction between the bacteria and their host. Here, we will review the immunology of TB and current vaccine candidates for TB. Current strategies of developing new vaccines against TB will also be reviewed in order to further discuss new insights into immunotherapeutic approaches involving adjuvant and antigens combinations that might be of potential for the control of TB.
机译:伴随着佐剂开发的最新进展和发现新的抗原的发现,用于传染性疾病的疫苗的开发已经走了很长一段路要走,这些新的抗原能够引起强烈的免疫学应答,以消灭疾病。每年杀死近200万人的结核病(TB)也是最近事态发展的亮点之一。感染诊断方法的可用性与是否对卫生系统控制疾病有影响,但与免疫监视无关,免疫监视是细菌与宿主之间相互作用的一种现象。在这里,我们将回顾结核病的免疫学和目前针对结核病的候选疫苗。为了进一步讨论对涉及佐剂和抗原组合的免疫治疗方法的新见解,这些策略还可能对控制结核病的潜在潜力进行新的见解,这些策略目前也将被综述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号